Zacks.com submits:

On March 3, 2010, Nile Therapeutics (NLTX) reported financial results for the fourth quarter and full year 2009. Nile reported no revenues for the fourth quarter or full year 2009.

Net loss for the fourth quarter totaled $1.6 million, or $0.06 per diluted share. For the full-year 2009, Nile reported a net loss of approximately $7.9 million, or $0.31 per diluted share.

Complete Story »

Further information:

Article source

Related posts:

1. eHealth, Inc. Announces Fourth Quarter and Fiscal 2009 Results
2. CAS Medical Systems, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results
3. Tenet Healthcare Tops Estimates as Revenues Rise
4. Lower Q4 Loss for Human Genome
5. Amerisafe: Substantial Q4 Miss